Search results for "MEDLINE"

showing 10 items of 2097 documents

Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA2LEN taskforce position…

2010

The aim of this Global Allergy and Asthma European Network (GA(2)LEN) consensus report is to provide recommendations for patient-reported outcomes (PROs) evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological economic and social impact. During the last 40 years, PROs have gained large consideration and use in the scientific community, to gain a better understanding of patients' subjective assessment with respect to elements concerning their health condition. They include all health-related reports coming from the patient, without involvement or interpretation by physician or others. PROs assessment should be performe…

medicine.medical_specialtyPediatricsImmunologyPopulationMEDLINEAlergiaHypersensitivity; Humans; Treatment Outcome; Clinical Trials as Topic; Quality of Life; Outcome Assessment (Health Care); Data CollectionOutcome Assessment (Health Care)Quality of life (healthcare)Outcome Assessment Health CareGlobal healthmedicineHypersensitivityHumansImmunology and AllergyeducationAsmaeducation.field_of_studyClinical Trials as Topicbusiness.industryData CollectionGa2LenGuidelinehumanitiesClinical trialTreatment OutcomeFamily medicineInclusion and exclusion criteriaQuality of LifePosition paperbusinessQualidade de VidaHuman
researchProduct

Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guid…

2011

The main reason for conducting a clinical trial (CT) is to test the effect of a drug or medical procedure to improve treatment of a disease. CTs contribute most when they are rigorously conducted and the results are published adequately. The aim of this study is to assess, using the CONSORT statement guidelines, the quality of reporting of completed CTs conducted at a tertiary hospital to determine which sections of the articles should be improved. CTs published between 2002 and 2008 were identified by searching the MEDLINE and Cochrane Library. Forty of 127 completed CTs were published. There was a marked increase in the number of articles and the quality of the journals that published the…

medicine.medical_specialtyPediatricsMedical procedureAlternative medicineMEDLINEGuidelines as TopicCochrane Librarylaw.inventionHospitals UniversityRandomized controlled triallawmedicineHumansPharmacology (medical)Randomized Controlled Trials as TopicPharmacologybusiness.industryConsolidated Standards of Reporting Trialsnervous system diseasesTest (assessment)Clinical trialSpainFamily medicineJournal Impact FactorPeriodicals as TopicbusinessJournal of clinical pharmacology
researchProduct

Agreement within Europe about antihypertensive treatment and education – results from the European Society of Hypertension questionnaire

2010

medicine.medical_specialtyPediatricsPhysiologybusiness.industrymedia_common.quotation_subjectMEDLINEAgreementEuropeFamily medicineHypertensionPractice Guidelines as TopicInternal MedicinemedicineHumansMulticenter Studies as TopicCardiology and Cardiovascular MedicinebusinessAntihypertensive Agentsmedia_commonJournal of Hypertension
researchProduct

Psycho-oncological care in certified cancer centres-a nationwide analysis in Germany

2012

Background Over the last few years, a nationwide voluntary certification system for cancer centres has been established in Germany. To qualify for certification, cancer centres must provide psycho-oncological care to every patient who needs it. The aim of this study was to find out how many patients have been treated by a psycho-oncologist in the certified centres. Methods All cancer centres in Germany that were re-certified in 2010 provided data documenting how many patients with primary cancer received at least 30 min of psycho-oncological consultation in 2009. Results Data from n = 456 certified cancer centres were available. In the centres, a total of 36 165 patients were seen by a psyc…

medicine.medical_specialtyPediatricsbusiness.industryColorectal cancereducationMEDLINECancerExperimental and Cognitive PsychologyCertificationmedicine.diseasehumanitiesPsychiatry and Mental healthProstate cancerBreast cancerOncologyFamily medicineHealth caremedicinebusinessLung cancerPsycho-Oncology
researchProduct

Patienten-Daten-Management in der Intensivtherapie - Pro und Kontra

1998

medicine.medical_specialtyPediatricsbusiness.industryPublic healthMEDLINEGeneral MedicinePatient dataCritical Care and Intensive Care Medicinemedicine.diseaseAnesthesiology and Pain MedicineCritical care nursingIntensive careHealth careEmergency MedicinemedicineMedical emergencybusinessQuality assuranceAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct

Parental informed consent in pediatric cancer trials: A population-based survey in Germany

2012

In Germany, nearly every child afflicted by a malignant dis-ease or a central nervous system tumor is enrolled in a clinicaltrial during treatment. Many of these children are under the age of5 years when they are first diagnosed [1]. The decision whether ornot to participate in a clinical trial is normally made by theparents on behalf of their child. Therefore, ensuring adequatelyinformed parental consent is essential to ethical practice in pedi-atric oncology.However, many empirical studies have revealed difficultieswith the informed consent process when parents are faced withthe decision to enroll their child in a clinical trial. Previous studyfindings have indicated that recalling signing th…

medicine.medical_specialtyPediatricseducation.field_of_studybusiness.industryPopulationMEDLINEContext (language use)HematologyPediatric cancer3. Good healthComprehensionClinical trial03 medical and health sciences0302 clinical medicineOncologyInformed consent030225 pediatrics030220 oncology & carcinogenesisFamily medicinePediatrics Perinatology and Child HealthmedicineParental consenteducationbusinessPediatric Blood & Cancer
researchProduct

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

2011

Three years after the introduction of natalizumab (NA) therapy for the second line treatment of relapsing-remitting multiple sclerosis (MS), Italian MS centers critically reviewed the scientific literature and their own clinical experience. Natalizumab was shown to be highly efficacious in the treatment of MS. However, the risk of progressive multifocal leukoencephalopathy was confirmed and defined better. This article summarizes the MS-SIN Study Group recommendations on the use of NA in MS, with particular reference to the appropriate selection and monitoring of patients as well as to the management of adverse events.

medicine.medical_specialtyPediatricspml; iris; multiple sclerosis; natalizumabMultiple SclerosisNeurologypmlMEDLINEProgressive MultifocalDermatologyRelapsing-RemittingAntibodies Monoclonal HumanizedAntibodiesLeukoencephalopathyMultiple Sclerosis Relapsing-RemittingNatalizumabLeukoencephalopathyMonoclonalmedicineHumansAdverse effectAntibodies; Monoclonal; Humanized Antibodies; therapeutic use Humans Leukoencephalopathy; Progressive Multifocal; chemically induced Multiple Sclerosis; Relapsing-Remitting; drug therapyHumanizedMultiple sclerosis Natalizumab PML IRISirisbusiness.industryNatalizumabProgressive multifocal leukoencephalopathyMultiple sclerosisLeukoencephalopathy Progressive MultifocalAntibodies MonoclonalGeneral Medicinemedicine.diseasedrug therapyPsychiatry and Mental healththerapeutic usechemically inducednatalizumab multiple sclerosis treatment guidelinesPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusinessmedicine.drug
researchProduct

Percutaneous tracheostomy in COVID patients. Experience in our hospital center after one year of pandemic and review of the literature

2021

Background The pandemic caused by SARS-COV-2 has caused an increase in the need of tracheostomies in patients affected with respiratory distress syndrome. In this article we report our experience during a year of pandemic, we develop our surgical technique to perform percutaneous tracheostomy with the patient in apnea and we compare our results with those of other centers through a bibliographic review. Material and Methods A one-year retrospective clinical study was carried out on tracheotomies performed on patients admitted to the intensive care unit with severe SARS-CoV-2, with difficulty for ventilation or weaning. The technique performed was percutaneous, with fibroscopic control throu…

medicine.medical_specialtyPercutaneousMEDLINEReviewlaw.inventionTracheostomylawPandemicmedicineHumansextrafollicular aotPandemicsGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective StudiesRespiratory distressindian populationSARS-CoV-2business.industryodontogenic tumorGeneral surgeryCOVID-19Apneaadenomatoid odontogenic tumor (aot)Respiration ArtificialIntensive care unitHospitalsfollicular aotOtorhinolaryngologySurgeryOral Surgerymedicine.symptomAirwaybusinessComplicationMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Fully percutaneous insertion and removal of the Impella CP via a subclavian approach

2020

The Impella (Abiomed) is a mechanical circulatory support device which augments cardiac output, but may also unload a left ventricle during venoarterial extracorporeal membrane oxygenation (ECMO) [1]. However, the Impella requires an access to a large artery and this may be problematic in a severe peripheral arterial disease. The presented case demonstrates how to insert and remove the Impella CP via a subclavian approach without surgical cutting.

medicine.medical_specialtyPercutaneousText miningbusiness.industryImage in InterventionmedicineMEDLINERMedicineCardiology and Cardiovascular MedicinebusinessImpellaSurgeryPostępy w Kardiologii Interwencyjnej
researchProduct

Oral health related quality of life and determinant factors in patients with head and neck cancer.

2018

Background The present study aimed to measure the impact of oral health on the quality of life of patients with head and neck cancer. Material and Methods A cross-sectional study was conducted with 130 patients diagnosed with head and neck cancer at two medical centers. Participants answered a sociodemographic questionnaire and the Oral Health Impact Profile - 14 (OHIP-14). Clinical aspects, cancer staging, and treatment approach were also investigated. Mann-Whitney and Kruskal-Wallis non-parametric tests were used for statistical analysis, followed by Poisson regression analysis (with robust error variance), to associate the OHIP-14 scores with independent variables. Results The OHIP-14 pr…

medicine.medical_specialtyPhysical disabilityCross-sectional studyMEDLINEOral Health03 medical and health sciencessymbols.namesake0302 clinical medicineQuality of lifeCronbach's alphaInternal medicineSurveys and QuestionnairesmedicineHumansPoisson regressionGeneral DentistryCancer stagingOral Medicine and Pathologybusiness.industryResearchHead and neck cancer030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Cross-Sectional StudiesOtorhinolaryngologyHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASsymbolsQuality of LifeSurgerybusinessMedicina oral, patologia oral y cirugia bucal
researchProduct